Author:
Atack John R.,Pike Andy,Marshall George,Stanley Jo,Lincoln Rachael,Cook Susan M.,Lewis Richard T.,Blackaby Wesley P.,Goodacre Simon C.,McKernan Ruth M.,Dawson Gerard R.,Wafford Keith A.,Reynolds David S.
Subject
Cellular and Molecular Neuroscience,Pharmacology
Reference54 articles.
1. The use of benzodiazepines in anxiety and other disorders;Argyropoulos;European Neuropsychopharmacology,1999
2. The benzodiazepine binding site of GABAA receptors as a target for the development of novel anxiolytics;Atack;Expert Opinion on Investigational Drugs,2005
3. Regional differences in the inhibition of mouse in vivo [3H]Ro 15-1788 binding reflect selectivity for α1 versus α2 and α3 subunit-containing GABAA receptors;Atack;Neuropsychopharmacology,1999
4. Anxiogenic properties of an inverse agonist selective for α3 subunit-containing GABAA receptors;Atack;British Journal of Pharmacology,2005
5. TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for α2- and α3-containing GABAA receptors, is a non-sedating anxiolytic in rodents and primates;Atack;Journal of Pharmacology and Experimental Therapeutics,2006
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献